AsianScientist (May 23, 2016) – The government of Japan will be making a US$130 million contribution to the Global Health Innovative Technology Fund (GHIT Fund)/United Nations Development Program (UNDP) replenishment. This decision signals Japan’s unwavering support for research and development (R&D) into malaria, tuberculosis, HIV/AIDS and neglected tropical diseases (NTDs) worldwide.
The first of its kind in Japan, GHIT Fund is a public-private partnership involving the Japanese government, Japan’s leading life science companies, the Bill & Melinda Gates Foundation, the Wellcome Trust and UNDP.
“We are tremendously appreciative of the Japanese government’s US$130 million contribution to the GHIT Fund/UNDP program, and applaud its ongoing and now renewed support of our work in product development,” said GHIT Fund CEO, Dr. BT Slingsby.
“Today’s announcement is a testament to Japanese leadership in our global community, and speaks loudly and clearly that for Japan, innovation in global health is an essential priority, today and for the future.”
Launched in 2013 as a public and private partnership, the GHIT Fund has built a robust portfolio of drugs, vaccines and diagnostics. The Fund is expanding: it has invested upwards of US$60 million in more than 60 global product development partnerships that leverage Japanese innovation and capacities in pharmaceuticals.
The government’s support will not only allow this innovative work to continue, but will enable GHIT to expand its global development partnerships and its reach around the world. GHIT drives forward product development of new technologies to eliminate NTDs and, with over half of its investments targeting resistance in malaria and tuberculosis, is also committed to fight against antimicrobial resistance.
“Since our initial commitment three years ago, GHIT has made incredible progress in leveraging Japan’s vast cutting-edge science and technology know-how for game-changing tools that have the potential to one day save millions of lives across the globe,” said Dr. Eiji Hinoshita, director of the Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs of Japan.
“With today’s announcement, we are incredibly proud to be able to support the continued advancement of these innovations, which, with their rapid advancement through the pipeline, are already poised to make real our vision of a healthier world.”
GHIT is working with its partners from industry and at the Bill & Melinda Gates Foundation and Wellcome Trust to realize its full replenishment.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.